Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Balance the Superfood Shot
AddedFeb 17, 2024
UpdatedJun 18, 2026
Balance the Superfood Shot

Balance the Superfood Shot

Seed

Life Equals, a Kansas City-based health supplement startup, specializes in premium, bio-available superfood shots since 2011.

HQ
Lenexa, KS, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded in 2011 and based in Kansas City, Life Equals specializes in premium, bio-available superfood shots designed to promote preventative health using whole food blends. The company's core mission is to make nutrition accessible and convenient, offering a range of products including Foundation, Turmeric, Immunity, Energy, Active Digestion, and MAX Energy blends. Their market focus is on health-conscious consumers seeking easy and effective ways to incorporate essential nutrients into their daily routines.

Notable figures affiliated with Life Equals include its founders, who have driven the company’s vision of enhancing health through natural supplements. Key achievements include the successful launch and market penetration of their superfood shots, which have garnered positive reviews for their efficacy and convenience. The overall impact of Life Equals has been significant in promoting healthier lifestyles by providing accessible nutritional solutions, thereby contributing to the growing trend of preventative health care.

Balance the Superfood Shot - Quick Facts

When was Balance the Superfood Shot founded?

Balance the Superfood Shot was founded in 2011.

Where is Balance the Superfood Shot's headquarters located?

Balance the Superfood Shot's headquarters is located in Lenexa, KS, US.

When was Balance the Superfood Shot's last funding round?

Balance the Superfood Shot's most recent funding round was for $2.4M (USD) in January 2019.

How much has Balance the Superfood Shot raised to-date?

As of Jan 31, 2019, Balance the Superfood Shot has raised a total of $3.1M (USD).

How many employees does Balance the Superfood Shot have?

Balance the Superfood Shot has 30 employees as of Feb 4, 2024.

Balance the Superfood Shot - Classification

Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Superfood Shots
Tags
  • eCommerce
  • Healthtech
NAICS
  • 440000Retail Trade
  • 445000Food and Beverage Retailers
SIC
  • 5400Food Stores
  • 5490Miscellaneous Food Stores
Show 1 more industry code
SIC
  • 5900Miscellaneous Retail